GD
EXAS

Grandfield & Dodd’s Exact Sciences EXAS Stock Holding History

Grandfield & Dodd’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-107,468
Closed -$10.9M – 212
2025
Q4 		$10.9M Sell
107,468
-6,357
-6% -$510K 0.62% 48
2025
Q3 		$6.23M Sell
113,825
-2,722
-2% -$136K 0.35% 57
2025
Q2 		$6.19M Buy
116,547
+3,787
+3% +$192K 0.36% 57
2025
Q1 		$4.88M Buy
112,760
+3,799
+3% +$192K 0.3% 60
2024
Q4 		$6.12M Buy
108,961
+4,962
+5% +$309K 0.38% 55
2024
Q3 		$7.08M Buy
103,999
+24,103
+30% +$1.36M 0.42% 52
2024
Q2 		$3.38M Buy
79,896
+24,672
+45% +$1.36M 0.21% 66
2024
Q1 		$3.81M Buy
55,224
+32,453
+143% +$2.05M 0.24% 61
2023
Q4 		$1.68M Buy
+22,771
New +$1.49M 0.12% 86

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Grandfield & Dodd's EXAS Position: Q1 2026 in Review

Grandfield & Dodd sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 107,468 shares — an estimated $10.9M sold.

Grandfield & Dodd first reported a position in EXAS in Q4 2023 and held it in 9 quarters. The position peaked at $10.9M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Grandfield & Dodd reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Grandfield & Dodd sold 107,468 Exact Sciences shares in Q1 2026, an estimated $10.9M.
  • Grandfield & Dodd first reported a position in Exact Sciences in Q4 2023 and held it in 9 quarters.
  • Grandfield & Dodd's Exact Sciences position peaked at $10.9M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Grandfield & Dodd's 13F filing for Q1 2026, filed 7 May 2026.